Page last updated: 2024-09-04

2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine and resiquimod

2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine has been researched along with resiquimod in 1 studies

Compound Research Comparison

Studies
(2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine)
Trials
(2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine)
Recent Studies (post-2010)
(2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine)
Studies
(resiquimod)
Trials
(resiquimod)
Recent Studies (post-2010) (resiquimod)
460746514318

Protein Interaction Comparison

ProteinTaxonomy2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine (IC50)resiquimod (IC50)
7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)2.056

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Radsak, MP; Rammensee, HG; Salih, HR; Schild, H1

Other Studies

1 other study(ies) available for 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine and resiquimod

ArticleYear
Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.
    Journal of immunology (Baltimore, Md. : 1950), 2004, Apr-15, Volume: 172, Issue:8

    Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Apoptosis; Cell Degranulation; Cell Survival; Cysteine; Humans; Imidazoles; Ligands; Lipopolysaccharides; Lipoproteins; Membrane Glycoproteins; Myeloid Cells; Neutrophil Activation; Neutrophils; Phagocytosis; Receptors, Cell Surface; Receptors, Immunologic; Respiratory Burst; Signal Transduction; Toll-Like Receptors; Triggering Receptor Expressed on Myeloid Cells-1

2004